HOME › DRUGS › LEVODOPA
ACTIVE SUBSTANCE / INN

LEVODOPA

Brand name(s): CARBIDOPA, LEVODOPA AND ENTACAPONE, CARBIDOPA AND LEVODOPA, CARBILEV, CREXONT, Inbrija, CARBIDOPA; LEVODOPA, LARODOPA, DHIVY, INBRIJA
FDA LISTED
EMA LISTED
PRESCRIPTION
DISCONTINUED
AUTHORISED
NDA217186
ANDA076643
ACTIVE SUBSTANCE
Levodopa
REGULATORS
FDA · EMA
SPONSORS / MAH
ROCHE, RANBAXY, IMPAX LABS
TOTAL APPLICATIONS
11
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
CARBIDOPA AND LEVODOPAANDA078893RISINGPrescription
CARBIDOPA, LEVODOPA AND ENTACAPONEANDA079085SUN PHARMDiscontinued
CARBIDOPA AND LEVODOPAANDA090631IMPAX LABSDiscontinued
INBRIJANDA209184MERZPrescription
CREXONTNDA217186IMPAXPrescription
DHIVYNDA214869AVION PHARMSPrescription
CARBILEVANDA076643RANBAXYDiscontinued
CARBIDOPA; LEVODOPAANDA208895SANDOZ INCNone (Tentative Approval)
LARODOPANDA016912ROCHEDiscontinued
CARBIDOPA, LEVODOPA AND ENTACAPONEANDA214495MACLEODS PHARMS LTDPrescription
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
InbrijaMerz Therapeutics GmbHAuthorised19/09/2019Parkinson Disease

FULL INTELLIGENCE ON LEVODOPA

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →